MARKET

CDXS

CDXS

Codexis Inc
NASDAQ
1.710
+0.440
+34.65%
Pre Market: 1.630 -0.08 -4.68% 04:36 03/13 EDT
OPEN
1.930
PREV CLOSE
1.270
HIGH
2.130
LOW
1.630
VOLUME
1.57K
TURNOVER
0
52 WEEK HIGH
3.870
52 WEEK LOW
0.9583
MARKET CAP
154.45M
P/E (TTM)
-2.2764
1D
5D
1M
3M
1Y
5Y
1D
Codexis Earnings Call: ECOsynthesis Momentum Amid Risks
TipRanks · 10h ago
Codexis (CDXS) Q4 Profit Turns Positive EPS Into Test Of Turnaround Narrative
Simply Wall St · 12h ago
Codexis Posts Strong Q4, Eyes siRNA Market With ECO Synthesis Platform
Seeking Alpha · 17h ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 17h ago
Thursday Sector Leaders: Oil & Gas Refining & Marketing, Chemicals
NASDAQ · 18h ago
Dow Tumbles Over 1%; US Weekly Jobless Claims Fall
Benzinga · 20h ago
Entera Takes Final Step Towards Phase 3, Accelerating Timeline for First Oral Anabolic Osteoporosis Therapy
TipRanks · 21h ago
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 22h ago
More
About CDXS
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Webull offers Codexis Inc stock information, including NASDAQ: CDXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXS stock methods without spending real money on the virtual paper trading platform.